Literature DB >> 32729255

Sarcopenia and low muscle radiodensity associate with impaired FEV1 in allogeneic haematopoietic stem cell transplant recipients.

Asmita Mishra1, Kevin D Bigam2, Martine Extermann3, Rawan Faramand1, Kerry Thomas4, Joseph A Pidala1, Vickie E Baracos2.   

Abstract

BACKGROUND: Quantification of skeletal muscle using computed tomography (CT) is accessible using cancer patients' standard oncologic images. Reduced muscle mass may be related to reduced respiratory muscle strength; however, the impact of this on lung functional parameters is not characterized in adult allogeneic haematopoietic stem cell transplant (alloHCT) recipients.
METHODS: A consecutive retrospective series (n = 296) of patients who had alloHCT at a comprehensive cancer centre between March 2005 and April 2015 were included. Pre-transplant CT scans were used to quantify skeletal muscle and adipose tissue at the fourth thoracic (T4) and/or third lumbar (L3) level. Tumour and patient characteristics were recorded, including forced expiratory volume in 1 second (FEV1 ) by spirometry. Regression models were created to characterize predictive relationships.
RESULTS: A total of 296 patients (♂n = 161; ♀n = 135) were included, all of whom had chest CT as part of standard care; a subset of these (n = 215, 72.6%) also had abdominal CT. Diagnoses were non-Hodgkins lymphoma (n = 165), acute myeloid leukaemia (n = 66), Hodgkin's disease (n = 14), acute lymphocytic leukaemia (n = 14), myelodysplastic syndromes (n = 18), and other (n = 19). In multivariable linear regression adjusted for sex (P < 0.0001), age (P < 0.0001), haematopoietic cell transplantation-specific co-morbidity index (P = 0.010), and parameters of pulmonary function testing (defined by spirometry, P < 0.0001), both T4 muscle index [β 0.127 (95% confidence interval 0.019; 0.252), P < 0.0001] and T4 muscle radiodensity [β 0.132 (95% confidence interval 0.087; 0.505), P = 0.006] were independently associated with FEV1 ; disease risk index (P = 0.877) and Karnofsky performance status (P = 0.548) were not associated with FEV1 . Similar conclusions were obtained when L3 muscle index and radiodensity were considered. Unlike T4, L3 muscle index values can be compared with published cut-off values for sarcopenia. Overall rates of sarcopenia were uniformly higher in the HCT population than in age-matched and sex-matched patients with solid tumours [alloHCT ♂64.7% vs. solid tumour ♂56.6% (P < 0.001); alloHCT ♀57.6% vs. solid tumour ♀36.0% (P < 0.001)]. Significant but moderate correlations (P < 0.001) were found for muscle area and radiodensity between L3 and T4, for both men and women; adipose tissue quantity also correlated significantly (P < 0.001) between L3 and T4 for both men and women.
CONCLUSIONS: Lumbar or thoracic CT images are useful for body composition assessment in this population and reveal high rates of sarcopenia, similar to those reported in very elderly patients. Reduced muscle mass and radiodensity associate with impaired FEV1 even after adjustment for clinical covariables including co-morbidities, performance status, disease risk, and mild intrinsic pulmonary disease (chronic obstructive pulmonary disease) defined by spirometry.
© 2020 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders.

Entities:  

Keywords:  Allogeneic haematopoietic transplantation; Forced expiratory volume; Muscle radiodensity; Sarcopenia

Year:  2020        PMID: 32729255     DOI: 10.1002/jcsm.12604

Source DB:  PubMed          Journal:  J Cachexia Sarcopenia Muscle        ISSN: 2190-5991            Impact factor:   12.910


  6 in total

Review 1.  The role and therapeutic potential of stem cells in skeletal muscle in sarcopenia.

Authors:  Zijun Cai; Di Liu; Yuntao Yang; Wenqing Xie; Miao He; Dengjie Yu; Yuxiang Wu; Xiuhua Wang; Wenfeng Xiao; Yusheng Li
Journal:  Stem Cell Res Ther       Date:  2022-01-24       Impact factor: 6.832

2.  Nutritional status and skeletal muscle status in patients with head and neck cancer: Impact on outcomes.

Authors:  Merran Findlay; Kathryn White; Chris Brown; Judith D Bauer
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-10-21       Impact factor: 12.910

3.  Sarcopenia is not associated with inspiratory muscle strength but with expiratory muscle strength among older adults requiring long-term care/support.

Authors:  Yohei Sawaya; Takahiro Shiba; Masahiro Ishizaka; Tamaki Hirose; Ryo Sato; Akira Kubo; Tomohiko Urano
Journal:  PeerJ       Date:  2022-02-17       Impact factor: 2.984

4.  Reference values of skeletal muscle area for diagnosis of sarcopenia using chest computed tomography in Asian general population.

Authors:  Sung Woo Moon; Sang Hoon Lee; Ala Woo; Ah Young Leem; Su Hwan Lee; Kyung Soo Chung; Eun Young Kim; Ji Ye Jung; Young Ae Kang; Moo Suk Park; Young Sam Kim; Chang Oh Kim; Song Yee Kim
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-02-15       Impact factor: 12.910

5.  Prognostic value of cachexia index in patients with colorectal cancer: A retrospective study.

Authors:  Qianyi Wan; Qian Yuan; Rui Zhao; Xiaoding Shen; Yi Chen; Tao Li; Yinghan Song
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

6.  Percentile-based averaging and skeletal muscle gauge improve body composition analysis: validation at multiple vertebral levels.

Authors:  J Peter Marquardt; Eric J Roeland; Emily E Van Seventer; Till D Best; Nora K Horick; Ryan D Nipp; Florian J Fintelmann
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-11-02       Impact factor: 12.910

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.